

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.13744552 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.13744552 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.13744552 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.13744552 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.13744552 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.13744552 |
| 7 | melanin biosynthetic process (GO:0042438) | 5.72215150 |
| 8 | melanin metabolic process (GO:0006582) | 5.53189093 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.09882587 |
| 10 | secondary metabolite biosynthetic process (GO:0044550) | 5.06903874 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92475663 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.70620211 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.60753824 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.58286866 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14902685 |
| 16 | neutrophil mediated immunity (GO:0002446) | 4.12389977 |
| 17 | pigment cell differentiation (GO:0050931) | 4.08590866 |
| 18 | melanocyte differentiation (GO:0030318) | 4.08504951 |
| 19 | natural killer cell mediated immunity (GO:0002228) | 4.06720393 |
| 20 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.06720393 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.00253496 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.97578671 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.97578671 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.97442002 |
| 25 | response to muramyl dipeptide (GO:0032495) | 3.91272881 |
| 26 | response to host immune response (GO:0052572) | 3.90775524 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.90775524 |
| 28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.84170591 |
| 29 | pinocytosis (GO:0006907) | 3.80809252 |
| 30 | response to peptidoglycan (GO:0032494) | 3.79211136 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 3.75951826 |
| 32 | apoptotic cell clearance (GO:0043277) | 3.75849140 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.72517503 |
| 34 | cellular extravasation (GO:0045123) | 3.68962969 |
| 35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.65899665 |
| 36 | response to host (GO:0075136) | 3.65899665 |
| 37 | response to host defenses (GO:0052200) | 3.65899665 |
| 38 | mannose metabolic process (GO:0006013) | 3.56377272 |
| 39 | cellular response to ethanol (GO:0071361) | 3.53614584 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48837677 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.47271040 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.44206392 |
| 43 | tryptophan catabolic process (GO:0006569) | 3.44206392 |
| 44 | indole-containing compound catabolic process (GO:0042436) | 3.44206392 |
| 45 | microglial cell activation (GO:0001774) | 3.43644045 |
| 46 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.42859742 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.40700742 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38996068 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38996068 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36977354 |
| 51 | germinal center formation (GO:0002467) | 3.27236981 |
| 52 | neutrophil activation (GO:0042119) | 3.25749212 |
| 53 | I-kappaB phosphorylation (GO:0007252) | 3.24433983 |
| 54 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.22584153 |
| 55 | negative regulation of granulocyte differentiation (GO:0030853) | 3.21997542 |
| 56 | regulation of integrin activation (GO:0033623) | 3.19062075 |
| 57 | regulation of cholesterol storage (GO:0010885) | 3.18265359 |
| 58 | granulocyte activation (GO:0036230) | 3.18147746 |
| 59 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15923058 |
| 60 | positive thymic T cell selection (GO:0045059) | 3.12084487 |
| 61 | respiratory burst (GO:0045730) | 3.07994006 |
| 62 | myeloid leukocyte mediated immunity (GO:0002444) | 3.07592542 |
| 63 | indolalkylamine metabolic process (GO:0006586) | 3.06249121 |
| 64 | cell adhesion mediated by integrin (GO:0033627) | 3.05914747 |
| 65 | NAD biosynthetic process (GO:0009435) | 3.05027501 |
| 66 | macrophage activation (GO:0042116) | 3.03806849 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 3.02979570 |
| 68 | opioid receptor signaling pathway (GO:0038003) | 3.02434996 |
| 69 | negative regulation of mast cell activation (GO:0033004) | 3.02383042 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 2.99926204 |
| 71 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99816796 |
| 72 | positive regulation of interferon-beta production (GO:0032728) | 2.99390500 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 2.95482261 |
| 74 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.93403748 |
| 75 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.91569549 |
| 76 | wound healing, spreading of epidermal cells (GO:0035313) | 2.91216982 |
| 77 | modulation by symbiont of host cellular process (GO:0044068) | 2.89271145 |
| 78 | B cell mediated immunity (GO:0019724) | 2.88754970 |
| 79 | negative regulation of interleukin-1 production (GO:0032692) | 2.88347142 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 2.88207977 |
| 81 | regulation of B cell differentiation (GO:0045577) | 2.85557794 |
| 82 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85076788 |
| 83 | defense response to protozoan (GO:0042832) | 2.84821299 |
| 84 | low-density lipoprotein particle clearance (GO:0034383) | 2.84612246 |
| 85 | pigment granule organization (GO:0048753) | 2.83204575 |
| 86 | leukocyte mediated cytotoxicity (GO:0001909) | 2.82340422 |
| 87 | regulation of mast cell degranulation (GO:0043304) | 2.81608918 |
| 88 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.81024086 |
| 89 | positive regulation of p38MAPK cascade (GO:1900745) | 2.80966839 |
| 90 | melanosome organization (GO:0032438) | 2.80314199 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 2.79893199 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.79634813 |
| 93 | tryptophan metabolic process (GO:0006568) | 2.79100663 |
| 94 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.78363103 |
| 95 | B cell homeostasis (GO:0001782) | 2.76586484 |
| 96 | lipoprotein transport (GO:0042953) | 2.74948757 |
| 97 | response to laminar fluid shear stress (GO:0034616) | 2.74634797 |
| 98 | leukocyte aggregation (GO:0070486) | 2.72097593 |
| 99 | negative regulation of lipid storage (GO:0010888) | 2.70002007 |
| 100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.67856865 |
| 101 | positive regulation of defense response to virus by host (GO:0002230) | 2.66061766 |
| 102 | positive regulation of mast cell activation (GO:0033005) | 2.65773782 |
| 103 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.65700317 |
| 104 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.65473920 |
| 105 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.64893567 |
| 106 | kynurenine metabolic process (GO:0070189) | 2.64230555 |
| 107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.61951806 |
| 108 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.61951806 |
| 109 | tyrosine metabolic process (GO:0006570) | 2.61418970 |
| 110 | leukocyte cell-cell adhesion (GO:0007159) | 2.59989961 |
| 111 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.59837015 |
| 112 | response to protozoan (GO:0001562) | 2.58377387 |
| 113 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.57119073 |
| 114 | cytokine secretion (GO:0050663) | 2.56617830 |
| 115 | lymphocyte mediated immunity (GO:0002449) | 2.55928260 |
| 116 | regulation of mast cell activation (GO:0033003) | 2.55584484 |
| 117 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.55151219 |
| 118 | regulation of phagocytosis (GO:0050764) | 2.55126869 |
| 119 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54634316 |
| 120 | regulation of leukocyte degranulation (GO:0043300) | 2.53455266 |
| 121 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52567859 |
| 122 | positive regulation of T cell apoptotic process (GO:0070234) | 2.52178986 |
| 123 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.51914845 |
| 124 | cortical actin cytoskeleton organization (GO:0030866) | 2.51906696 |
| 125 | ketone body metabolic process (GO:1902224) | 2.51719778 |
| 126 | myeloid cell homeostasis (GO:0002262) | 2.51224315 |
| 127 | detection of other organism (GO:0098543) | 2.50751646 |
| 128 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.50559157 |
| 129 | response to pheromone (GO:0019236) | 2.50473264 |
| 130 | positive regulation of phagocytosis (GO:0050766) | 2.50319545 |
| 131 | neuroepithelial cell differentiation (GO:0060563) | 2.50234981 |
| 132 | proline transport (GO:0015824) | 2.49166855 |
| 133 | endosome to pigment granule transport (GO:0043485) | 2.48584002 |
| 134 | endosome to melanosome transport (GO:0035646) | 2.48584002 |
| 135 | phenol-containing compound biosynthetic process (GO:0046189) | 2.47635428 |
| 136 | fucose catabolic process (GO:0019317) | 2.46514230 |
| 137 | L-fucose metabolic process (GO:0042354) | 2.46514230 |
| 138 | L-fucose catabolic process (GO:0042355) | 2.46514230 |
| 139 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.46430365 |
| 140 | lysosome organization (GO:0007040) | 2.46129469 |
| 141 | lytic vacuole organization (GO:0080171) | 2.46129469 |
| 142 | cellular response to ATP (GO:0071318) | 2.40841968 |
| 143 | detection of external biotic stimulus (GO:0098581) | 2.39822988 |
| 144 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.38480391 |
| 145 | negative regulation of T cell mediated immunity (GO:0002710) | 2.38154616 |
| 146 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.36487382 |
| 147 | detection of bacterium (GO:0016045) | 2.36382509 |
| 148 | cellular response to exogenous dsRNA (GO:0071360) | 2.35160390 |
| 149 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.32927340 |
| 150 | amino sugar catabolic process (GO:0046348) | 2.31522366 |
| 151 | amine catabolic process (GO:0009310) | 2.30736300 |
| 152 | cellular biogenic amine catabolic process (GO:0042402) | 2.30736300 |
| 153 | activated T cell proliferation (GO:0050798) | 2.30348913 |
| 154 | piRNA metabolic process (GO:0034587) | 2.27945296 |
| 155 | superoxide anion generation (GO:0042554) | 2.27775648 |
| 156 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.26633497 |
| 157 | response to type I interferon (GO:0034340) | 2.26324904 |
| 158 | reactive oxygen species biosynthetic process (GO:1903409) | 2.25637781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.53241581 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.45997601 |
| 3 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66998856 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.45688468 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.43862636 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.43674643 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22806334 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.22497259 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16419735 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.13765861 |
| 11 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92910199 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.84222474 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77522177 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.58717600 |
| 15 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.46250509 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.41828482 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.33610763 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31376463 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.30049303 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23281318 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20917785 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19323029 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.13633100 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12423249 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09063371 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05294494 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.01975113 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01514926 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.97552747 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.93505278 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92101328 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.91473291 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.88658809 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86687107 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81554983 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80337800 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.78884983 |
| 38 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.77811244 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77086056 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77037975 |
| 41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75154191 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72490730 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.71716432 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69323540 |
| 45 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.65134599 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65044450 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.63751174 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61405056 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60990533 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.60857908 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57248601 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57120555 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51899279 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51721278 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48067510 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47862939 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47790081 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47505370 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47425576 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.46748304 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44239279 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39786418 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39517245 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39177495 |
| 65 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.38006262 |
| 66 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38006262 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36146078 |
| 68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35023177 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34808772 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33844740 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32541058 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32535627 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29435017 |
| 74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27865336 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26249727 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25646866 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23705375 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23219530 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22051091 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21128037 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18967290 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18407695 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17810195 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16617737 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16569572 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16061075 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.15294932 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15174849 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14707484 |
| 90 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14224779 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13937919 |
| 92 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12795227 |
| 93 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.12491055 |
| 94 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12490478 |
| 95 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11888990 |
| 96 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11407794 |
| 97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11395130 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10309130 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09897514 |
| 100 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.09710014 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09073631 |
| 102 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.08800857 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08594566 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08309236 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08004204 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07599540 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06487020 |
| 108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03560567 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03414161 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03225808 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01200668 |
| 112 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.00875807 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00722682 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00317713 |
| 115 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00170275 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00021871 |
| 117 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99436525 |
| 118 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98891695 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98724467 |
| 120 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98011885 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97999737 |
| 122 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96695023 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96158030 |
| 124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95140471 |
| 125 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95026143 |
| 126 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95026143 |
| 127 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94772186 |
| 128 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.93880343 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93605075 |
| 130 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93185054 |
| 131 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92227087 |
| 132 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.92213542 |
| 133 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91936363 |
| 134 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91889380 |
| 135 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91706958 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90366148 |
| 137 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89956304 |
| 138 | ERA_21632823_ChIP-Seq_H3396_Human | 0.89496109 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89271842 |
| 140 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.89192948 |
| 141 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89020454 |
| 142 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88569308 |
| 143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88401019 |
| 144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88365104 |
| 145 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88221720 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87211963 |
| 147 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86871716 |
| 148 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86679163 |
| 149 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86305918 |
| 150 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86024517 |
| 151 | * BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.85182447 |
| 152 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.84794956 |
| 153 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83626978 |
| 154 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83626978 |
| 155 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83492349 |
| 156 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.83244020 |
| 157 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83217507 |
| 158 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.82841599 |
| 159 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82453881 |
| 160 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82202662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.46064432 |
| 2 | MP0000372_irregular_coat_pigmentation | 4.23314172 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.80889982 |
| 4 | MP0003136_yellow_coat_color | 3.77408891 |
| 5 | MP0005171_absent_coat_pigmentation | 3.38735209 |
| 6 | MP0005075_abnormal_melanosome_morpholog | 3.07278454 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.04397441 |
| 8 | MP0003172_abnormal_lysosome_physiology | 3.04060251 |
| 9 | MP0004381_abnormal_hair_follicle | 2.93799802 |
| 10 | MP0003303_peritoneal_inflammation | 2.92689134 |
| 11 | MP0003436_decreased_susceptibility_to | 2.78153823 |
| 12 | MP0009278_abnormal_bone_marrow | 2.52354522 |
| 13 | MP0002419_abnormal_innate_immunity | 2.47777472 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.41070294 |
| 15 | MP0002095_abnormal_skin_pigmentation | 2.27557058 |
| 16 | MP0000685_abnormal_immune_system | 2.25460585 |
| 17 | MP0005408_hypopigmentation | 2.23311418 |
| 18 | MP0006082_CNS_inflammation | 2.20037221 |
| 19 | MP0005377_hearing/vestibular/ear_phenot | 2.17230938 |
| 20 | MP0003878_abnormal_ear_physiology | 2.17230938 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.17139027 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.12370617 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.09873596 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.04927124 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.04859178 |
| 26 | MP0001800_abnormal_humoral_immune | 2.04803764 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 2.01793308 |
| 28 | MP0009840_abnormal_foam_cell | 1.99730770 |
| 29 | MP0004947_skin_inflammation | 1.99643091 |
| 30 | MP0001790_abnormal_immune_system | 1.99276623 |
| 31 | MP0005387_immune_system_phenotype | 1.99276623 |
| 32 | MP0005025_abnormal_response_to | 1.98515120 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.94541918 |
| 34 | MP0001958_emphysema | 1.87998318 |
| 35 | MP0004510_myositis | 1.86283761 |
| 36 | MP0002723_abnormal_immune_serum | 1.84011559 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.77649673 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.76602173 |
| 39 | MP0001819_abnormal_immune_cell | 1.74318717 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.74142172 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.73939590 |
| 42 | MP0003646_muscle_fatigue | 1.73761974 |
| 43 | MP0003195_calcinosis | 1.72057454 |
| 44 | MP0009785_altered_susceptibility_to | 1.70348258 |
| 45 | MP0002405_respiratory_system_inflammati | 1.65990795 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.64404705 |
| 47 | MP0010307_abnormal_tumor_latency | 1.63883417 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.61626202 |
| 49 | MP0005310_abnormal_salivary_gland | 1.60584767 |
| 50 | MP0001853_heart_inflammation | 1.59982581 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.59759730 |
| 52 | MP0005671_abnormal_response_to | 1.56621977 |
| 53 | MP0003448_altered_tumor_morphology | 1.56405499 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.54923451 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.54923451 |
| 56 | MP0005257_abnormal_intraocular_pressure | 1.54897560 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.54420086 |
| 58 | MP0002075_abnormal_coat/hair_pigmentati | 1.54250091 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.45021586 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.44951326 |
| 61 | MP0001873_stomach_inflammation | 1.43379217 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.39130299 |
| 63 | MP0000858_altered_metastatic_potential | 1.38647226 |
| 64 | MP0002398_abnormal_bone_marrow | 1.37609520 |
| 65 | MP0000716_abnormal_immune_system | 1.36017780 |
| 66 | MP0003279_aneurysm | 1.35792792 |
| 67 | MP0000604_amyloidosis | 1.34883048 |
| 68 | MP0003724_increased_susceptibility_to | 1.34867674 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.33983663 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.32174700 |
| 71 | MP0001851_eye_inflammation | 1.32009785 |
| 72 | MP0001324_abnormal_eye_pigmentation | 1.31770884 |
| 73 | MP0002102_abnormal_ear_morphology | 1.31237418 |
| 74 | MP0002254_reproductive_system_inflammat | 1.30730060 |
| 75 | MP0002006_tumorigenesis | 1.30558494 |
| 76 | MP0000371_diluted_coat_color | 1.28949035 |
| 77 | MP0002933_joint_inflammation | 1.26077138 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.24541619 |
| 79 | MP0002722_abnormal_immune_system | 1.24176510 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.22299679 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.21928895 |
| 82 | MP0001968_abnormal_touch/_nociception | 1.21915304 |
| 83 | MP0003690_abnormal_glial_cell | 1.18824401 |
| 84 | MP0005023_abnormal_wound_healing | 1.18181595 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 1.17711552 |
| 86 | MP0000343_altered_response_to | 1.16417488 |
| 87 | MP0002429_abnormal_blood_cell | 1.15698758 |
| 88 | MP0010155_abnormal_intestine_physiology | 1.15458251 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 1.13706107 |
| 90 | MP0008469_abnormal_protein_level | 1.13287168 |
| 91 | MP0003091_abnormal_cell_migration | 1.11038318 |
| 92 | MP0000427_abnormal_hair_cycle | 1.01555159 |
| 93 | MP0005451_abnormal_body_composition | 1.01511733 |
| 94 | MP0001186_pigmentation_phenotype | 0.94021898 |
| 95 | MP0003075_altered_response_to | 0.93974714 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.93829474 |
| 97 | MP0005365_abnormal_bile_salt | 0.92928311 |
| 98 | MP0000490_abnormal_crypts_of | 0.92647879 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.90972991 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.90495634 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.89595408 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.87699740 |
| 103 | MP0002736_abnormal_nociception_after | 0.87150718 |
| 104 | MP0003763_abnormal_thymus_physiology | 0.85167337 |
| 105 | MP0002837_dystrophic_cardiac_calcinosis | 0.83763039 |
| 106 | MP0004043_abnormal_pH_regulation | 0.83716090 |
| 107 | MP0001243_abnormal_dermal_layer | 0.81935428 |
| 108 | MP0008260_abnormal_autophagy | 0.81609816 |
| 109 | MP0004130_abnormal_muscle_cell | 0.80773562 |
| 110 | MP0009763_increased_sensitivity_to | 0.80424932 |
| 111 | MP0005410_abnormal_fertilization | 0.80103342 |
| 112 | MP0005390_skeleton_phenotype | 0.79680052 |
| 113 | MP0009046_muscle_twitch | 0.79323214 |
| 114 | MP0001986_abnormal_taste_sensitivity | 0.79257420 |
| 115 | MP0001915_intracranial_hemorrhage | 0.79256877 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.79126241 |
| 117 | MP0002735_abnormal_chemical_nociception | 0.77992764 |
| 118 | MP0003806_abnormal_nucleotide_metabolis | 0.77846779 |
| 119 | MP0004185_abnormal_adipocyte_glucose | 0.77547175 |
| 120 | MP0005166_decreased_susceptibility_to | 0.77055025 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.76898673 |
| 122 | MP0000733_abnormal_muscle_development | 0.75584764 |
| 123 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75312373 |
| 124 | MP0005647_abnormal_sex_gland | 0.75104833 |
| 125 | MP0002168_other_aberrant_phenotype | 0.74963892 |
| 126 | MP0003828_pulmonary_edema | 0.74753353 |
| 127 | MP0009764_decreased_sensitivity_to | 0.74473730 |
| 128 | MP0010329_abnormal_lipoprotein_level | 0.74095892 |
| 129 | MP0004742_abnormal_vestibular_system | 0.73843812 |
| 130 | MP0005360_urolithiasis | 0.73490140 |
| 131 | MP0002060_abnormal_skin_morphology | 0.72389121 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.72120576 |
| 133 | MP0000249_abnormal_blood_vessel | 0.71362727 |
| 134 | MP0005621_abnormal_cell_physiology | 0.71147584 |
| 135 | MP0003795_abnormal_bone_structure | 0.70140385 |
| 136 | MP0001663_abnormal_digestive_system | 0.69378948 |
| 137 | MP0005670_abnormal_white_adipose | 0.66587868 |
| 138 | MP0002229_neurodegeneration | 0.65584148 |
| 139 | MP0000470_abnormal_stomach_morphology | 0.64942866 |
| 140 | MP0003879_abnormal_hair_cell | 0.64648458 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.64161299 |
| 142 | MP0000609_abnormal_liver_physiology | 0.64145288 |
| 143 | MP0003045_fibrosis | 0.61013131 |
| 144 | MP0002019_abnormal_tumor_incidence | 0.60451929 |
| 145 | MP0002733_abnormal_thermal_nociception | 0.57450704 |
| 146 | MP0002090_abnormal_vision | 0.56707262 |
| 147 | MP0003252_abnormal_bile_duct | 0.56262685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.87901175 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.31072507 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.85903449 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.41421399 |
| 5 | Ocular albinism (HP:0001107) | 4.39991059 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.05666098 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.97951450 |
| 8 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.97087070 |
| 9 | Hypoplasia of the fovea (HP:0007750) | 3.97087070 |
| 10 | Iris hypopigmentation (HP:0007730) | 3.80164429 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.79016920 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.77002530 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.77002530 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.77002530 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.74861642 |
| 16 | Hyperventilation (HP:0002883) | 3.69774940 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.65427962 |
| 18 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.47374638 |
| 19 | Blue irides (HP:0000635) | 3.46807678 |
| 20 | Gingivitis (HP:0000230) | 3.41343753 |
| 21 | Albinism (HP:0001022) | 3.40506818 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.37420303 |
| 23 | Periodontitis (HP:0000704) | 3.34669242 |
| 24 | Recurrent skin infections (HP:0001581) | 3.29838852 |
| 25 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.20319376 |
| 26 | Disinhibition (HP:0000734) | 3.14813442 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.11687909 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.07334069 |
| 29 | Generalized hypopigmentation of hair (HP:0011358) | 3.06228197 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.01628731 |
| 31 | Axonal loss (HP:0003447) | 3.01604500 |
| 32 | Clumsiness (HP:0002312) | 3.01603627 |
| 33 | Stomatitis (HP:0010280) | 2.99432434 |
| 34 | Abnormality of the fovea (HP:0000493) | 2.95223265 |
| 35 | Congenital sensorineural hearing impairment (HP:0008527) | 2.89911410 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.86992039 |
| 37 | Pustule (HP:0200039) | 2.86926923 |
| 38 | Generalized hypopigmentation (HP:0007513) | 2.85975256 |
| 39 | Cerebral aneurysm (HP:0004944) | 2.85370313 |
| 40 | Loss of speech (HP:0002371) | 2.78860913 |
| 41 | Myositis (HP:0100614) | 2.78069623 |
| 42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70996480 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70996480 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70996480 |
| 45 | Myocardial infarction (HP:0001658) | 2.70871296 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.68086256 |
| 47 | Hematochezia (HP:0002573) | 2.66396596 |
| 48 | Congenital stationary night blindness (HP:0007642) | 2.62186382 |
| 49 | Protruding tongue (HP:0010808) | 2.61385162 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61364360 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.61364360 |
| 52 | Stomach cancer (HP:0012126) | 2.61352630 |
| 53 | Colitis (HP:0002583) | 2.59013691 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.57438913 |
| 55 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.57438913 |
| 56 | Recurrent viral infections (HP:0004429) | 2.57094596 |
| 57 | Cellulitis (HP:0100658) | 2.54929289 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.54016045 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.50179654 |
| 60 | Thick nail (HP:0001805) | 2.49718150 |
| 61 | Prostate neoplasm (HP:0100787) | 2.48934831 |
| 62 | Premature loss of primary teeth (HP:0006323) | 2.47729933 |
| 63 | Osteomyelitis (HP:0002754) | 2.43076723 |
| 64 | Encephalitis (HP:0002383) | 2.42373283 |
| 65 | Abnormal drinking behavior (HP:0030082) | 2.42339450 |
| 66 | Polydipsia (HP:0001959) | 2.42339450 |
| 67 | Global brain atrophy (HP:0002283) | 2.37402478 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34114518 |
| 69 | Obstructive lung disease (HP:0006536) | 2.34114518 |
| 70 | Ulnar bowing (HP:0003031) | 2.29344851 |
| 71 | Attenuation of retinal blood vessels (HP:0007843) | 2.27022913 |
| 72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26854028 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26854028 |
| 74 | Abnormality of the renal cortex (HP:0011035) | 2.26853145 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.26010740 |
| 76 | Thoracic kyphosis (HP:0002942) | 2.25721175 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.24726135 |
| 78 | Pathologic fracture (HP:0002756) | 2.23537614 |
| 79 | Abolished electroretinogram (ERG) (HP:0000550) | 2.21217597 |
| 80 | Leukocytosis (HP:0001974) | 2.19855391 |
| 81 | Hemoptysis (HP:0002105) | 2.19759674 |
| 82 | Orchitis (HP:0100796) | 2.19623352 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17651639 |
| 84 | Absent frontal sinuses (HP:0002688) | 2.16625996 |
| 85 | Gaze-evoked nystagmus (HP:0000640) | 2.15820620 |
| 86 | Hypopigmentation of the fundus (HP:0007894) | 2.15617107 |
| 87 | Urethral obstruction (HP:0000796) | 2.14996962 |
| 88 | Hypochromic anemia (HP:0001931) | 2.14702385 |
| 89 | Gingival bleeding (HP:0000225) | 2.13632480 |
| 90 | Severe visual impairment (HP:0001141) | 2.13563079 |
| 91 | Gastrointestinal inflammation (HP:0004386) | 2.13304161 |
| 92 | Abnormality of the thoracic spine (HP:0100711) | 2.13203525 |
| 93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13047619 |
| 94 | Pulmonary infiltrates (HP:0002113) | 2.08306421 |
| 95 | Vasculitis (HP:0002633) | 2.06640337 |
| 96 | Abnormal platelet function (HP:0011869) | 2.05135172 |
| 97 | Impaired platelet aggregation (HP:0003540) | 2.05135172 |
| 98 | White forelock (HP:0002211) | 2.03482042 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 2.02862612 |
| 100 | Agnosia (HP:0010524) | 2.02787890 |
| 101 | Abnormality of B cell number (HP:0010975) | 2.02773665 |
| 102 | Abnormality of the fingertips (HP:0001211) | 2.02595421 |
| 103 | Genetic anticipation (HP:0003743) | 2.02354424 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 2.02325648 |
| 105 | Glomerulonephritis (HP:0000099) | 2.01536155 |
| 106 | Increased CSF protein (HP:0002922) | 1.99763072 |
| 107 | Absent speech (HP:0001344) | 1.96698784 |
| 108 | Vertebral compression fractures (HP:0002953) | 1.96396334 |
| 109 | Aortic aneurysm (HP:0004942) | 1.95853057 |
| 110 | Chronic otitis media (HP:0000389) | 1.95635404 |
| 111 | Upper motor neuron abnormality (HP:0002127) | 1.95326455 |
| 112 | Prolonged bleeding time (HP:0003010) | 1.94715853 |
| 113 | Restrictive lung disease (HP:0002091) | 1.94595730 |
| 114 | Fair hair (HP:0002286) | 1.94594628 |
| 115 | Bone pain (HP:0002653) | 1.93221501 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92911756 |
| 117 | Pancreatic cysts (HP:0001737) | 1.92431493 |
| 118 | Increased density of long bones (HP:0006392) | 1.92111089 |
| 119 | Urticaria (HP:0001025) | 1.91643675 |
| 120 | Widely spaced teeth (HP:0000687) | 1.91513021 |
| 121 | Amelogenesis imperfecta (HP:0000705) | 1.90531839 |
| 122 | Chronic hepatic failure (HP:0100626) | 1.88131156 |
| 123 | Polyuria (HP:0000103) | 1.86536591 |
| 124 | Hepatosplenomegaly (HP:0001433) | 1.86125235 |
| 125 | Frequent falls (HP:0002359) | 1.86112948 |
| 126 | Bruising susceptibility (HP:0000978) | 1.84987837 |
| 127 | Epistaxis (HP:0000421) | 1.84879058 |
| 128 | Tubular atrophy (HP:0000092) | 1.83916289 |
| 129 | Emphysema (HP:0002097) | 1.83661444 |
| 130 | Mitral valve prolapse (HP:0001634) | 1.83433245 |
| 131 | Progressive inability to walk (HP:0002505) | 1.83344405 |
| 132 | Abnormality of the periventricular white matter (HP:0002518) | 1.83095632 |
| 133 | Spondylolisthesis (HP:0003302) | 1.82920476 |
| 134 | Basal ganglia calcification (HP:0002135) | 1.82837067 |
| 135 | Dilatation of the ascending aorta (HP:0005111) | 1.82456982 |
| 136 | Abnormality of the lumbar spine (HP:0100712) | 1.82433360 |
| 137 | Peripheral demyelination (HP:0011096) | 1.81864132 |
| 138 | Nephritis (HP:0000123) | 1.81689867 |
| 139 | Amyloidosis (HP:0011034) | 1.80051295 |
| 140 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.79303869 |
| 141 | Bile duct proliferation (HP:0001408) | 1.79070264 |
| 142 | Abnormal biliary tract physiology (HP:0012439) | 1.79070264 |
| 143 | Cheilitis (HP:0100825) | 1.78849107 |
| 144 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.77535975 |
| 145 | Polyphagia (HP:0002591) | 1.76525054 |
| 146 | Retinal atrophy (HP:0001105) | 1.76494377 |
| 147 | Neurodegeneration (HP:0002180) | 1.73995155 |
| 148 | Abnormality of the pleura (HP:0002103) | 1.73091873 |
| 149 | Type II lissencephaly (HP:0007260) | 1.72930766 |
| 150 | Tented upper lip vermilion (HP:0010804) | 1.72221297 |
| 151 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.72115068 |
| 152 | Mesangial abnormality (HP:0001966) | 1.71962201 |
| 153 | Radial bowing (HP:0002986) | 1.70965725 |
| 154 | Macular degeneration (HP:0000608) | 1.69300224 |
| 155 | Meningitis (HP:0001287) | 1.68269277 |
| 156 | Distal lower limb amyotrophy (HP:0008944) | 1.66786005 |
| 157 | Eosinophilia (HP:0001880) | 1.66435509 |
| 158 | Neuronal loss in central nervous system (HP:0002529) | 1.65652702 |
| 159 | Optic neuritis (HP:0100653) | 1.65053648 |
| 160 | Retrobulbar optic neuritis (HP:0100654) | 1.65053648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.88325671 |
| 2 | KIT | 3.19174988 |
| 3 | TRIB3 | 3.13315671 |
| 4 | MAP4K1 | 2.88298098 |
| 5 | TTN | 2.76079184 |
| 6 | TYK2 | 2.62782041 |
| 7 | ERN1 | 2.58663695 |
| 8 | RIPK4 | 2.51952092 |
| 9 | ADRBK2 | 2.50862270 |
| 10 | TBK1 | 2.34849551 |
| 11 | ACVR1B | 2.29145165 |
| 12 | IRAK3 | 2.19116967 |
| 13 | CAMK1D | 2.16466818 |
| 14 | BLK | 2.11186498 |
| 15 | TAOK3 | 2.08289942 |
| 16 | IRAK4 | 1.97701687 |
| 17 | BMPR1B | 1.92250575 |
| 18 | MAP3K14 | 1.89002130 |
| 19 | PKN2 | 1.87173915 |
| 20 | TNK2 | 1.84185360 |
| 21 | JAK3 | 1.82616737 |
| 22 | PTK6 | 1.82277206 |
| 23 | CDK12 | 1.81501198 |
| 24 | CAMK1G | 1.79024298 |
| 25 | MAP3K10 | 1.76621305 |
| 26 | RIPK1 | 1.74136478 |
| 27 | TGFBR2 | 1.71626058 |
| 28 | ZAP70 | 1.68095384 |
| 29 | JAK1 | 1.62771242 |
| 30 | SIK2 | 1.62681239 |
| 31 | CSF1R | 1.61459361 |
| 32 | STK10 | 1.57585252 |
| 33 | HCK | 1.53079791 |
| 34 | NEK9 | 1.51156802 |
| 35 | IKBKE | 1.50007718 |
| 36 | MAP3K13 | 1.43963950 |
| 37 | EPHB1 | 1.42141101 |
| 38 | MAP2K3 | 1.38935079 |
| 39 | IKBKB | 1.35656031 |
| 40 | CDC42BPA | 1.33701685 |
| 41 | OXSR1 | 1.32506890 |
| 42 | CDK6 | 1.31573660 |
| 43 | CSK | 1.30307953 |
| 44 | PIK3CG | 1.25466451 |
| 45 | RPS6KA4 | 1.23761594 |
| 46 | PINK1 | 1.19763150 |
| 47 | BTK | 1.19373422 |
| 48 | PAK4 | 1.15823073 |
| 49 | FES | 1.14873261 |
| 50 | SCYL2 | 1.10975113 |
| 51 | NEK2 | 1.10707303 |
| 52 | LRRK2 | 1.09227409 |
| 53 | SYK | 1.08675996 |
| 54 | PTK2B | 1.07790246 |
| 55 | LCK | 1.06312791 |
| 56 | PRKD2 | 1.03744559 |
| 57 | SIK1 | 1.02824772 |
| 58 | MAP3K9 | 1.02149597 |
| 59 | TXK | 0.98346161 |
| 60 | MAPK13 | 0.97323860 |
| 61 | ITK | 0.97301338 |
| 62 | TRPM7 | 0.96360480 |
| 63 | IRAK1 | 0.96011748 |
| 64 | FGR | 0.92489290 |
| 65 | MAP2K6 | 0.92070389 |
| 66 | JAK2 | 0.91903269 |
| 67 | INSRR | 0.90038940 |
| 68 | PRKAA2 | 0.88683310 |
| 69 | MARK3 | 0.86176393 |
| 70 | MAP3K3 | 0.86121735 |
| 71 | CHUK | 0.84232716 |
| 72 | GRK6 | 0.84067482 |
| 73 | PIM1 | 0.83855222 |
| 74 | FGFR4 | 0.82531046 |
| 75 | NME2 | 0.81317870 |
| 76 | LYN | 0.80285541 |
| 77 | MAP3K7 | 0.79942822 |
| 78 | EEF2K | 0.78899261 |
| 79 | GRK1 | 0.77474108 |
| 80 | DDR2 | 0.77315191 |
| 81 | TEC | 0.76807741 |
| 82 | WNK4 | 0.76270716 |
| 83 | FLT3 | 0.75159648 |
| 84 | EGFR | 0.74938355 |
| 85 | PDGFRB | 0.74542799 |
| 86 | MTOR | 0.73696076 |
| 87 | GRK7 | 0.72943574 |
| 88 | STK4 | 0.72923628 |
| 89 | CDK4 | 0.72722629 |
| 90 | MATK | 0.70720248 |
| 91 | WNK3 | 0.69863310 |
| 92 | BMX | 0.67381633 |
| 93 | TGFBR1 | 0.67244870 |
| 94 | CAMKK1 | 0.67071649 |
| 95 | CAMKK2 | 0.66583433 |
| 96 | MAPK11 | 0.64973483 |
| 97 | FGFR3 | 0.64090099 |
| 98 | MAP3K8 | 0.63791326 |
| 99 | BRD4 | 0.62806457 |
| 100 | ADRBK1 | 0.61293032 |
| 101 | PTK2 | 0.61165775 |
| 102 | MAP3K6 | 0.59767302 |
| 103 | SGK2 | 0.59646130 |
| 104 | STK3 | 0.59381102 |
| 105 | MAP3K11 | 0.59177696 |
| 106 | ABL1 | 0.58290426 |
| 107 | CAMK4 | 0.56635521 |
| 108 | PIM2 | 0.56104043 |
| 109 | CAMK1 | 0.55945717 |
| 110 | FER | 0.55030591 |
| 111 | PAK2 | 0.54106225 |
| 112 | MAPKAPK3 | 0.51768218 |
| 113 | ICK | 0.51470595 |
| 114 | MARK2 | 0.48855089 |
| 115 | MAP4K2 | 0.48353320 |
| 116 | CLK1 | 0.47165252 |
| 117 | PDK1 | 0.45960032 |
| 118 | NUAK1 | 0.45110593 |
| 119 | TAOK1 | 0.44743040 |
| 120 | RPS6KA6 | 0.44329081 |
| 121 | PDPK1 | 0.43879224 |
| 122 | TESK2 | 0.41848958 |
| 123 | STK39 | 0.41652099 |
| 124 | PRKCQ | 0.41337386 |
| 125 | SIK3 | 0.41166749 |
| 126 | FYN | 0.40154807 |
| 127 | MAPK12 | 0.40006055 |
| 128 | NTRK3 | 0.39153169 |
| 129 | SGK3 | 0.38971628 |
| 130 | PRKCZ | 0.38611001 |
| 131 | DAPK2 | 0.38522617 |
| 132 | RPS6KL1 | 0.38322046 |
| 133 | RPS6KC1 | 0.38322046 |
| 134 | MAPK7 | 0.37995308 |
| 135 | NLK | 0.37455233 |
| 136 | PDGFRA | 0.37089503 |
| 137 | PRKCH | 0.37038967 |
| 138 | STK38 | 0.36312711 |
| 139 | RPS6KA1 | 0.36082667 |
| 140 | MAP2K2 | 0.35110451 |
| 141 | IRAK2 | 0.35023387 |
| 142 | ATR | 0.33972596 |
| 143 | RPS6KA2 | 0.33721447 |
| 144 | SRC | 0.33710028 |
| 145 | YES1 | 0.31937472 |
| 146 | MAPKAPK2 | 0.31428141 |
| 147 | ALK | 0.30455568 |
| 148 | KDR | 0.29430138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69958995 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.67823354 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.61542831 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.57906282 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53656448 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44581028 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.29957157 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.12436258 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05883906 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01032181 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.96566907 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.94750035 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.90803177 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.90495326 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.86409653 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80180273 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.72929742 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.68558991 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65418646 |
| 20 | ABC transporters_Homo sapiens_hsa02010 | 1.64708931 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63402238 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.61009582 |
| 23 | Apoptosis_Homo sapiens_hsa04210 | 1.59376258 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.57802233 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.56802289 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.55939967 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51188298 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.49740604 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.47428070 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44444733 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42489785 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.40656666 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40490916 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38843465 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34517654 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34422298 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32810863 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31664827 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30419924 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29205869 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27110932 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26948882 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20525205 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19354072 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19174276 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17902061 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17071940 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15886239 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.15783051 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.14303225 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12878273 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.11177459 |
| 53 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10669528 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07788744 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07092610 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07074569 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06945741 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.05140196 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03390201 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 1.01053002 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.99956902 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97567319 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.96711298 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95421505 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.93922814 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92958825 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.92873192 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92570334 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92259207 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91240549 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90893805 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90278528 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89992802 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88525408 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86978340 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85457304 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79361135 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.78865755 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78612741 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77895689 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77507912 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76994447 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76715754 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76626468 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75693526 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75315128 |
| 87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73442362 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73007310 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.72967972 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72064578 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71773622 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.70936656 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67412794 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67398619 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67138111 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66408775 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65722675 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.64031059 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63505623 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.62749008 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.61832157 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61356124 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60710747 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60674607 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59538728 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58930918 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58519188 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57591672 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57432143 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56717599 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56497937 |
| 112 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55729493 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53906351 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.53672628 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53355154 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53175536 |
| 117 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52107395 |
| 118 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51643651 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50600579 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50532166 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50365594 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49364533 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49269312 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.48830169 |
| 125 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48255298 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47887532 |
| 127 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46792672 |
| 128 | Allograft rejection_Homo sapiens_hsa05330 | 0.46051498 |
| 129 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45087403 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44637329 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44217160 |
| 132 | Asthma_Homo sapiens_hsa05310 | 0.41694974 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41521650 |
| 134 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41404657 |
| 135 | Long-term depression_Homo sapiens_hsa04730 | 0.41368316 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.41290476 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40980609 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40565951 |
| 139 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40543395 |
| 140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40187867 |

